Ozempic is finally here — but it doesn’t come cheap. With costs touching ₹11,000 a month and generics still a year away, here ...

Novo Nordisk has launched Ozempic in India at ₹2,200 per week, expanding diabetes treatment options even as patent disputes ...

The weekly injection was approved by the US Food and Drug Administration in 2017 for people with type 2 diabetes.

The Delhi High Court has refused to halt a previous order that permits Dr Reddy’s Laboratories to produce and export a drug similar to Ozempic, the semaglutide-based medication widely used for ...

The dispute centres on Novo Nordisk's Indian patents for semaglutide, which it markets globally as Ozempic and Wegovy for ...

Eli Lilly and Co. announced December 9 that it would build a new $6 billion factory in Huntsville, Alabama for production of ...

The Delhi High Court has allowed Sun Pharmaceutical Industries Ltd. to manufacture and export its semaglutide-based drug, ...

Rising adoption of automated and AI-enabled synthesis platforms positions pharmaceutical and biotechnology companies for ...

Australia’s TGA has issued updated safety warnings for GLP-1 drugs like Ozempic and Mounjaro, highlighting mental-health ...

Companies say the EU’s deregulation efforts are insufficient against Trump's “carrot-and-stick” strategy of pairing generous ...

This year, Forbes ranked PSEG the No. 14 Best-In-State Employer for 2025 in New Jersey, reflecting the endorsement from a ...

The Delhi High Court declined to stay a single-judge order allowing Dr. Reddy's to export its semaglutide, observing Novo ...